Oberweis Asset Management »

Legend Biotech 2 Adr Rep Ord shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $963k 16k 60.17
2023-09-30 $1.1M 16k 67.17
2023-06-30 $828k 12k 69.03

More positions owned by Oberweis Asset Management

Constellium Se cl a (CSTM)
Axcelis Technologies (ACLS)
Aehr Test Systems (AEHR)
Alphatec Holdings (ATEC)
Weatherford Intl Ordf (WFRD)
Amphastar Pharmaceuticals (AMPH)
Veracyte (VCYT)
Applied Optoelectronics (AAOI)
Transmedics Group (TMDX)
Perion Network (PERI)
Universal Display Corporation (OLED)
Adma Biologics (ADMA)
Camtek (CAMT)
Vertiv Holdings Llc vertiv holdings (VRT)
Axonics Modulation Technolog (AXNX)

View all positions for Oberweis Asset Management

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
Wellington Management Company
Massachusetts Financial Services
Paradigm Biocapital Advisors
Henderson Group
Westfield Capital Management Company
Holocene Advisors
Federated Investors
Alliancebernstein
TimesSquare Capital Management
Arrowpoint Asset Management
Matthews International Capital Management
Avidity Partners Management

View all funds holding Legend Biotech 2 Adr Rep Ord